aTyr Pharma | LIFE - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Ardelyx USD 127.27M 7.15M 2026-03
aTyr Pharma USD 2.42M 83.19M 2026-03
Biogen USD 2.98B 1.02B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Cipla INR 62.31B 3.04B 2026-06
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.19M 96K 2026-03
CSL USD 5.7B 2.82B 2025-12
Curis USD 9.02M 23.01M 2025-12
GlaxoSmithKline GBP 5.8B 468M 2026-06
Grifols EUR 1.99B 217.4M 2025-12
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Novartis USD 10.2B 912M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
United Therapeutics USD 5.9B 5.1B 2026-03